Form 8-K - Current report:
SEC Accession No. 0001818382-25-000080
Filing Date
2025-06-11
Accepted
2025-06-11 16:08:08
Documents
14
Period of Report
2025-06-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K huma-20250610.htm   iXBRL 8-K 46997
2 EX-3.1 huma-20250610ex31.htm EX-3.1 10237
  Complete submission text file 0001818382-25-000080.txt   224851

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT huma-20250610.xsd EX-101.SCH 2182
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT huma-20250610_def.xml EX-101.DEF 16363
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT huma-20250610_lab.xml EX-101.LAB 28815
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT huma-20250610_pre.xml EX-101.PRE 17150
16 EXTRACTED XBRL INSTANCE DOCUMENT huma-20250610_htm.xml XML 4375
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39532 | Film No.: 251040037
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)